<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T16:42:53.9909981+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-ZAF-C-AFSA-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for Impact against Tuberculosis and HIV - South Africa (01-Apr-2016-31-Mar-2019)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">South Africa, TB/HIV, AIDS Foundation South Africa (AFSA)This program has the following goals: Ensuring an enabling and accessible legal framework that protects and promotes human rights in order to support implementation of the NSP.  Initiating at least 80% of eligible patients on antiretroviral treatment, with 70% alive and on treatment five years after initiation.  Reducing new HIV infections by at least 50%, using combination prevention approaches.  Reducing self-reported stigma related to HIV and TB by at least 50%.  Reducing the number of new TB infections and deaths from TB by 50%. The objectives of this program are: Addressing Social and Structural Drivers of HIV and TB Prevention, Care and Impact.  Ensuring protection of human rights and improving access to justice.  Preventing New HIV, STI and TB Infections.  Sustaining Health and Wellness</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<other-identifier ref="ZAF-C-AFSAP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2016-04-01" />
		<activity-date type="2" iso-date="2016-04-01" />
		<activity-date type="3" iso-date="2019-03-31" />
		<activity-date type="4" iso-date="2019-03-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">John, OCHERO</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>john.ochero@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="ZA" percentage="100">
			<narrative xml:lang="en">South Africa</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="100">
			<narrative xml:lang="en">TB/HIV</narrative>
		</sector>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<transaction ref="a2a84b9d-46fc-4569-ae6e-98b10f486211">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-10-03" />
			<value currency="USD" value-date="2017-10-03">1056839.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="194edb94-6ddb-44c3-aadc-1dcaf3eca23c">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-07-30" />
			<value currency="USD" value-date="2018-07-30">1648945.54</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f895f6bb-d122-4be7-95fd-6d66d3bf19d4">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-04-29" />
			<value currency="USD" value-date="2020-04-29">-802560.33</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a6b6413e-4023-41c8-bdc2-11647e0ad50b">
			<transaction-type code="2" />
			<transaction-date iso-date="2016-05-09" />
			<value currency="USD" value-date="2016-05-09">6650111.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a16d0c37-c62e-4fcf-aa45-7a066207087e">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-09-20" />
			<value currency="USD" value-date="2018-09-20">2384945.39</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="be5baed3-540d-48a2-b703-78c781b5d7af">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-11-30" />
			<value currency="USD" value-date="2017-11-30">4071926.63</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cd72d8ea-1352-444d-9726-cc1035c9e827">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-07-30" />
			<value currency="USD" value-date="2018-07-30">-210613.48</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="187d81db-d370-4794-a5b9-80af3e3dabfe">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-12-17" />
			<value currency="USD" value-date="2018-12-17">2560247.41</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fd419dc3-5635-4134-bc3f-e1655aedeb6d">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-12-01" />
			<value currency="USD" value-date="2017-12-01">647830.63</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cae55a60-5d6a-436c-88bb-c2dce3cb7aca">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-01-30" />
			<value currency="USD" value-date="2018-01-30">1782050.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="33f44d11-e7eb-4e94-b630-6b5d0eca407a">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-09-21" />
			<value currency="USD" value-date="2018-09-21">2384945.39</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9f19e086-43e9-4c0d-a442-fbbbf0676a68">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-05-09" />
			<value currency="USD" value-date="2019-05-09">170119.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e82e6726-1a63-49de-bc4e-6bc54fb37b6f">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-02-02" />
			<value currency="USD" value-date="2017-02-02">741905.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="37b8866d-ab57-467f-9c86-68003ed5892c">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-10-05" />
			<value currency="USD" value-date="2017-10-05">1056839.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c470ed8d-68ab-4086-8a09-d64f63af2a27">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-07-31" />
			<value currency="USD" value-date="2018-07-31">1648945.54</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2a32a703-b304-40fa-8eb2-6db9d1407aec">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-02-01" />
			<value currency="USD" value-date="2019-02-01">1587568.08</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c8e5cbf0-e59e-4d3e-90db-787a0479a47e">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-05-10" />
			<value currency="USD" value-date="2016-05-10">1177351.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0980dd7f-4102-4aa4-ab86-6b0e9b758c60">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-11-15" />
			<value currency="USD" value-date="2016-11-15">1114677.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="27b15f06-84f6-4635-bde1-07fe2ba0a905">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-04-19" />
			<value currency="USD" value-date="2018-04-19">1431432.52</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8dfec8cd-8b5a-4d5b-ade2-0fa881f7a074">
			<transaction-type code="3" />
			<transaction-date iso-date="2016-08-23" />
			<value currency="USD" value-date="2016-08-23">601092.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="376a8f1e-4b57-47ae-8ab9-16c1a22dd28d">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-04-13" />
			<value currency="USD" value-date="2017-04-13">2270585.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1a4bf144-62d3-433c-a3ff-f7d573b4864a">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-07-27" />
			<value currency="USD" value-date="2017-07-27">744501.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/ZAF-C-AFSA" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for ZAF-C-AFSAP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">YP-other 1: Percentage of adolescents ( aged 15-24 years) attending TVET colleges who receive a standardised package of prevention programmes from trained peer educators</narrative>
				</title>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="63.80" />
					<actual value="20.50" />
				</period>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="31.90" />
					<actual value="3.80" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="31.90" />
					<actual value="4.55" />
				</period>
				<period>
					<period-start iso-date="2018-04-01" />
					<period-end iso-date="2018-09-30" />
					<target value="10.60" />
					<actual value="10.80" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="21.30" />
					<actual value="19.80" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2018-03-31" />
					<target value="88.90" />
					<actual value="23.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">YP-other 2: Percentage of adolescents (aged 15-24 years) attending TVET colleges that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2018-04-01" />
					<period-end iso-date="2018-09-30" />
					<target value="5.30" />
					<actual value="7.00" />
				</period>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="24.10" />
					<actual value="10.70" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="24.10" />
					<actual value="11.23" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="10.60" />
					<actual value="10.50" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2018-03-31" />
					<target value="24.20" />
					<actual value="17.70" />
				</period>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="24.10" />
					<actual value="88.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="63.70" />
					<actual value="74.30" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="63.80" />
					<actual value="19.11" />
				</period>
				<period>
					<period-start iso-date="2018-04-01" />
					<period-end iso-date="2018-09-30" />
					<target value="63.60" />
					<actual value="68.30" />
				</period>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2018-03-31" />
					<target value="63.70" />
					<actual value="50.80" />
				</period>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="63.60" />
					<actual value="41.50" />
				</period>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="62.20" />
					<actual value="17.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations reached with HIV prevention programs - individual and/or smaller group level interventions</narrative>
				</title>
				<period>
					<period-start iso-date="2017-10-01" />
					<period-end iso-date="2018-03-31" />
					<target value="4.90" />
					<actual value="5.50" />
				</period>
				<period>
					<period-start iso-date="2016-10-01" />
					<period-end iso-date="2017-03-31" />
					<target value="2.70" />
					<actual value="1.10" />
				</period>
				<period>
					<period-start iso-date="2016-04-01" />
					<period-end iso-date="2016-09-30" />
					<target value="1.30" />
					<actual value="0.44" />
				</period>
				<period>
					<period-start iso-date="2018-10-01" />
					<period-end iso-date="2019-03-31" />
					<target value="4.90" />
					<actual value="5.60" />
				</period>
				<period>
					<period-start iso-date="2018-04-01" />
					<period-end iso-date="2018-09-30" />
					<target value="2.50" />
					<actual value="3.10" />
				</period>
				<period>
					<period-start iso-date="2017-04-01" />
					<period-end iso-date="2017-09-30" />
					<target value="2.50" />
					<actual value="1.40" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for ZAF-C-AFSAP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2018-04-01" />
					<period-end iso-date="2018-09-30" />
					<target value="81.00" />
					<actual value="52178" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HIV O-other 3: Percentage of adults viral load suppressed 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2018-04-01" />
					<period-end iso-date="2018-09-30" />
					<target value="85.00" />
					<actual value="70.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2018-04-01" />
					<period-end iso-date="2018-09-30" />
					<target value="60.00" />
					<actual value="51.94" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2018-04-01" />
					<period-end iso-date="2018-09-30" />
					<target value="94.00" />
					<actual value="77.92" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-ZAF-C-AFSA-3</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for impact against Tuberculosis and HIV - South Africa (01-Apr-2022-30-Sep-2025)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">South Africa, TB/HIV, AIDS Foundation South Africa (AFSA)This program has the following goals: Accelerate prevention to reduce new HIV and TB infections and STIs.  Reduce morbidity and mortality by providing treatment, care and adherence support for all.  Reach all key and vulnerable populations with customised and targeted interventions.  Address the social and structural drivers of HIV, TB and STIs, and lin these effort to the National Development Plan.  Ground the response to HIV, TB and STIs in human rights principles and approaches.  Promote leadership and shared accountability for sustainable response to HIV, TB and STIs.  Mobilise resources and maximise efficiencies to support the achievment of NSP goals and ensure a sustainable approach.  Strengthen strategic information to drive progress towards achievement of NSP goals. The objectives of this program are: Reduce new HIV infections to less than 100,000 by 2022 through combination prevention interventions.  Implement the 95-95-95 strategy for HIV.  Increase engagment, collaboration and advocacy of key and vulnerable populations in the development and implementation of social and health support activities.  To provide an enabling environment to increase access to health services by key and vulnerable populations.  Implement social and behaviour change programmes to address key drivers of the epidemic and build social cohesion.  Implement economic strengthening programmes with a focus on youth and sex workers in priority focus districts.  Promote an environment that enables and protects human and legal rights and prevents stigma and discrimination.  Strengthen AIDS Councils to provide effective co-ordination and leadership of all stakeholders for shared accountability in the implementation of the NSP.  Improve efficiency and mobilise sufficient resources to achieve the goals, objective and targets of the NSP.  Optimise routinely collected strategic health information for data utilisation in decision making</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<other-identifier ref="ZAF-C-AFSAP03" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="4" />
		<activity-date type="1" iso-date="2022-04-01" />
		<activity-date type="2" iso-date="2022-04-01" />
		<activity-date type="3" iso-date="2025-09-30" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">John, OCHERO</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>john.ochero@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="ZA" percentage="100">
			<narrative xml:lang="en">South Africa</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="49">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="31">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="19">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="1">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Addressing stigma, discrimination and violence</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="26">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Community empowerment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Comprehensive sexuality education for AGYW and adolescent boys and young men (ABYM)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Condom and lubricant programing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Gender-based violence prevention and post violence care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Harm reduction interventions for drug use</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Interventions for young key populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Prevention and management of co-infections and co-morbidities (Prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Social protection interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and polices relating to HIV and HIV/TB</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy (“Know Your Rights” campaign)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Case management, clinical operations and therapeutics</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Country-level coordination and planning</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-based organizations institutional capacity building</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Social mobilization</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Gender-based violence prevention and post violence care (COVID-19)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Health products and waste management systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for HIV programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Respond to human rights and gender related barriers to services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk communication</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Surveillance: Epidemiological investigation and contact tracing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="21">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; HRH policy and governance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="11">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Others</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2024-01-01" />
			<period-end iso-date="2024-12-31" />
			<value currency="USD" value-date="2022-04-01">31797574.55</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2025-01-01" />
			<period-end iso-date="2025-12-31" />
			<value currency="USD" value-date="2022-04-01">21313901.26</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2022-04-01">18451291.82</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2022-04-01">29983221.04</value>
		</budget>
		<transaction ref="a208a0bd-e5a2-4923-a760-5fdae3f6c6c2">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-07-29" />
			<value currency="USD" value-date="2025-07-29">-2029981.49</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="91beb248-d08c-40ad-bb72-974a4541ca50">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-13" />
			<value currency="USD" value-date="2023-12-13">49673708.76</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="76ff424c-b423-4306-be64-1bc181914a21">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-07-05" />
			<value currency="USD" value-date="2022-07-05">58714084.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="18bbe820-b356-48d1-865c-b9456aded3d1">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-11-18" />
			<value currency="USD" value-date="2024-11-18">-40276.43</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="931e6015-7a92-4f38-8f1f-917458962601">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-13" />
			<value currency="USD" value-date="2023-12-13">-16374695.15</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8ce53ab1-e711-4c1d-b51a-8c01e1364620">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-12-19" />
			<value currency="USD" value-date="2025-12-19">195964.77</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="709e4ebd-1bca-48cb-a421-56e45cd12d27">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-12-07" />
			<value currency="USD" value-date="2024-12-07">19563676.48</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b2122c9f-b3ec-4f6d-8915-2e7b87788928">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-12-07" />
			<value currency="USD" value-date="2024-12-07">-20161566.01</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="527b0fc3-8e3c-420c-a481-bb9a16b943b2">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-07-29" />
			<value currency="USD" value-date="2025-07-29">4854327.56</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e2bf3428-96ca-4f5e-817c-c0ff6ef45ec0">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-05-19" />
			<value currency="USD" value-date="2023-05-19">3634530.26</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f45f8b5c-46db-487c-8f49-68cda8e5052e">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-03-04" />
			<value currency="USD" value-date="2025-03-04">5522168.67</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bd3573a6-c07f-4736-9248-2ba3021ec25f">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-07-07" />
			<value currency="USD" value-date="2022-07-07">6770673.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="660d0785-e857-4dc0-8931-31614f980580">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-05-27" />
			<value currency="USD" value-date="2025-05-27">3474732.10</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9543d97d-9d1c-4901-932a-c9307e4667de">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-03-01" />
			<value currency="USD" value-date="2024-03-01">1342865.83</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4f88e17d-3d43-4b91-9e97-c386f2a8c3cd">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-04-04" />
			<value currency="USD" value-date="2024-04-04">8230673.14</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9fcf2d35-c8a8-49c6-83b8-4bf90b53d6f3">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-11-03" />
			<value currency="USD" value-date="2022-11-03">7696335.18</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9a69fe03-34c2-4ede-a24b-4b25756e977e">
			<transaction-type code="3" />
			<transaction-date iso-date="2026-01-13" />
			<value currency="USD" value-date="2026-01-13">195964.77</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2603b19c-fd48-406b-9ab0-5ee7708a73df">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-05" />
			<value currency="USD" value-date="2023-10-05">741774.74</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6cd1d52e-b74d-4d06-a8d4-e43ca19d8cf3">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-08-05" />
			<value currency="USD" value-date="2025-08-05">4253154.90</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="bcfd1f84-e348-448e-81da-223d7c267dfe">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-02-21" />
			<value currency="USD" value-date="2023-02-21">4748833.56</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="aea76f21-d103-406f-93f0-270aa2b52df4">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-11-03" />
			<value currency="USD" value-date="2022-11-03">1654404.45</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="3cf2d5d7-311c-45b6-a92f-4a6f81d786f1">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-08-03" />
			<value currency="USD" value-date="2023-08-03">1487961.03</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cdf9d6f0-fc77-4713-8a70-e4ac6aa3af1f">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-12-10" />
			<value currency="USD" value-date="2024-12-10">8536794.22</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="63b9a65f-aae1-45fb-9d7f-9ba864169525">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-11-14" />
			<value currency="USD" value-date="2024-11-14">-40276.43</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="34e3cd3d-093f-4e14-b860-9cddcd8e4de9">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-08-03" />
			<value currency="USD" value-date="2023-08-03">4332747.89</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2e1f7df4-ed30-4605-8fb8-9580ac69d32a">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-05-19" />
			<value currency="USD" value-date="2023-05-19">1742202.76</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0947d7b0-2b53-4f65-b256-f54adfed59a2">
			<transaction-type code="3" />
			<transaction-date iso-date="2025-11-18" />
			<value currency="USD" value-date="2025-11-18">601172.66</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0ea80fe0-961e-43c5-9261-0300015398eb">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-05-30" />
			<value currency="USD" value-date="2024-05-30">12619869.96</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="84a1744c-7ca3-4ec4-ac67-81a455f54d15">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-10-05" />
			<value currency="USD" value-date="2023-10-05">5632956.74</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a777d2e7-54a2-4e47-b03b-12113e589655">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-19" />
			<value currency="USD" value-date="2023-12-19">8661599.65</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c7558dfa-6eb8-4d2d-b333-b59bca33b160">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-03-01" />
			<value currency="USD" value-date="2024-03-01">2554103.41</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP03.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/ZAF-C-AFSA" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for ZAF-C-AFSAP03</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="64.00" />
					<actual value="70.20" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="85.00" />
					<actual value="129.90" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="75.00" />
					<actual value="90.50" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="77.00" />
					<actual value="95.10" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="75.00" />
					<actual value="90.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adolescent girls and young women reached with HIV prevention programs- defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="56.00" />
					<actual value="23.00" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="60.00" />
					<actual value="47.00" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="60.00" />
					<actual value="47.00" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="70.00" />
					<actual value="81.80" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="65.00" />
					<actual value="50.90" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people newly diagnosed with HIV initiated on ART</narrative>
				</title>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="95.00" />
					<actual value="73.90" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="95.00" />
					<actual value="93.50" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="95.00" />
					<actual value="77.70" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="95.00" />
					<actual value="79.60" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="95.00" />
					<actual value="89.60" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of community organizations that received a pre-defined package of training</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="26" />
					<actual value="26" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="25" />
					<actual value="27" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="26" />
					<actual value="26" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="26" />
					<actual value="26" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HR-Other 2: Number of analytical reports generated from a functional national human rights reporting system on human rights violations based on inputs from local level users</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="2" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="2" />
					<actual value="2" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="2" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="2" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="4" />
					<actual value="2" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">YP-Other 2 Percentage of adolescent boys and young men reached with HIV prevention programs- defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="20.00" />
					<actual value="21.90" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="15.00" />
					<actual value="21.80" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="10.00" />
					<actual value="10.70" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="15.00" />
					<actual value="21.80" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="25.00" />
					<actual value="27.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">KP Other-1: Number of male sexual partners that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="29535" />
					<actual value="28026" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="27304" />
					<actual value="23785" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="45507" />
					<actual value="28136" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="18203" />
					<actual value="4351" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="29535" />
					<actual value="24738" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">CSS-Other 1: Percentage of CSOs capacitated through the program that successfully attracted a small grant (any donor) and has begun implementation</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="50.00" />
					<actual value="76.90" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="52.00" />
					<actual value="52.00" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="50.00" />
					<actual value="50.00" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="50.00" />
					<actual value="50.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="99.00" />
					<actual value="121.50" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="99.00" />
					<actual value="97.80" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="99.00" />
					<actual value="121.50" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="100.00" />
					<actual value="126.20" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="100.00" />
					<actual value="148.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">YP-Other 1: Percentage of eligible other vulnerable populations who initiated oral antiretroviral PrEP during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="11.00" />
					<actual value="9.30" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="11.00" />
					<actual value="11.60" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="11.00" />
					<actual value="9.80" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="8.00" />
					<actual value="12.00" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="9.60" />
					<actual value="10.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="37.00" />
					<actual value="30.60" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="27.00" />
					<actual value="12.20" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="40.00" />
					<actual value="34.80" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="44.00" />
					<actual value="35.80" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="37.00" />
					<actual value="30.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of eligible sex workers who initiated oral antiretroviral PrEP during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="27.00" />
					<actual value="32.00" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="28.00" />
					<actual value="25.90" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2023-03-31" />
					<target value="21.10" />
					<actual value="28.90" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="28.00" />
					<actual value="28.70" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="21.00" />
					<actual value="31.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HR-Other 1: Number of police and other law enforcement officers in Global Fund-supported districts reached by training  program</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="1000" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="600" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2023-04-01" />
					<period-end iso-date="2023-09-30" />
					<target value="1000" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2022-04-01" />
					<period-end iso-date="2022-09-30" />
					<target value="400" />
					<actual value="0" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of young people aged 10-24 years attending school reached by compehensive sexuality education and/or life skills-based HIV education in schools</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="20.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="40.00" />
					<actual value="35.10" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for ZAF-C-AFSAP03</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reporting using a condom with their most recent client</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="95.00" />
					<actual value="0.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HIV O-Other 1: Delivery in age 10-19 in facility rate</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="12.80" />
				</period>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="13.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations who report the use of a condom at last sexual intercourse</narrative>
				</title>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="90.00" />
					<actual value="48.80" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for ZAF-C-AFSAP03</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of new HIV infections per 1000 uninfected population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="3.71" />
					<actual value="2.78" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="3.54" />
					<actual value="2.41" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="60.70" />
					<actual value="58.80" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="59.00" />
					<actual value="53.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of other vulnerable populations (specify) who are living with HIV</narrative>
				</title>
				<period>
					<period-start iso-date="2022-10-01" />
					<period-end iso-date="2023-03-31" />
					<target value="9.70" />
					<actual value="8.70" />
				</period>
				<period>
					<period-start iso-date="2023-10-01" />
					<period-end iso-date="2024-03-31" />
					<target value="9.40" />
					<actual value="8.10" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-ZAF-C-AFSA-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Investing for impact against Tuberculosis and HIV - South Africa (01-Apr-2019-31-Mar-2022)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">South Africa, TB/HIV, AIDS Foundation South Africa (AFSA)This program has the following goals: Accelerate prevention to reduce new HIV and TB infections and STIs.  Reduce morbidity and mortality by providing treatment, care and adherence support for all.  Reach all key and vulnerable populations with customised and targeted interventions.  Address the social and structural drivers of HIV, TB and STIs, and lin these effort to the National Development Plan.  Ground the response to HIV, TB and STIs in human rights principles and approaches.  Promote leadership and shared accountability for sustainable response to HIV, TB and STIs.  Mobilise resources and maximise efficiencies to support the achievment of NSP goals and ensure a sustainable approach.  Strengthen strategic information to drive progress towards achievement of NSP goals. The objectives of this program are: 1.1 Reduce new HIV infections to less than 100,000 by 2022 through combination prevention interventions.  2.1 Implement the 90-90-90 strategy for HIV.  2.2 Implement the 90-90-90 Strategy for TB.  3.1 Increase engagment, collaboration and advocacy of key and vulnerable populations in the development and implementation of social and health support activities.  3.2 To provide an enabling environment to increase access to health services by key and vulnerable populations.  4.1 Implement social and behaviour change programmes to address key drivers of the epidemic and build social cohesion.  4.4 Implement and scale up a package of harm reduction interventions for harmful use of alcohol and drugs in all districts.  4.5 Implement economic strengthening programmes with a focus on youth in priority focus districts.  5.3 Promote an environment that enables and protects human and legal rights and prevents stigma and discrimination.  6.1 Strengthen AIDS Councils to provide effective co-ordination and leadership of all stakeholders for shared accountability in the implementation of the NSP.  7.1 Improve efficiency and mobilise sufficient resources to achieve the goals, objective and targets of the NSP.  8.1 Optimise routinely collected strategic health information for data utilisation in decision making</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="15" role="2">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<participating-org type="15" role="3">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<participating-org type="15" role="4">
			<narrative xml:lang="en">AIDS Foundation South Africa</narrative>
		</participating-org>
		<other-identifier ref="ZAF-C-AFSAP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2019-04-01" />
		<activity-date type="2" iso-date="2019-04-01" />
		<activity-date type="3" iso-date="2022-03-31" />
		<activity-date type="4" iso-date="2022-03-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">John, OCHERO</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>john.ochero@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="ZA" percentage="100">
			<narrative xml:lang="en">South Africa</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="56">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="33">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="11">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Differentiated HIV testing services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Addressing stigma, discrimination and legal barriers to care for adolescents and youth</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="10">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Behavioral change as part of programs for adolescent and youth</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Gender-based violence prevention and treatment programs for adolescents and youth</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; HIV testing services for adolescents and youth, in and out of school</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Keeping girls in school</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Linkages of HIV, RMNCH, and TB programs for adolescents, girls, and young women</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="8">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Other intervention(s) for adolescent and youth</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Pre-exposure prophylaxis (PrEP) for adolescents and youth</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Socioeconomic approaches</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and polices relating to HIV and HIV/TB</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy (“Know Your Rights” campaign)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Country-level coordination and planning</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 control and containment including health systems strengthening</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-based organizations institutional capacity building</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led advocacy and research</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 CSS: Community-led monitoring</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Gender-based violence prevention and post violence care (COVID-19)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Health products and waste management systems</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Infection prevention and control, and protection of the health workforce</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Mitigation for HIV programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Respond to human rights and gender related barriers to services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk communication</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk mitigation for disease programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Surveillance: Epidemiological investigation and contact tracing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="14">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2019-04-01">46964825.40</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2019-04-01">17008840.94</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2019-04-01">7391667.88</value>
		</budget>
		<transaction ref="e571f8f7-68e3-4875-bcc6-33172588e9ce">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-10-12" />
			<value currency="USD" value-date="2021-10-12">-1897409.81</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="49e2c9d7-337c-4307-9184-9332407d733d">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-11-18" />
			<value currency="USD" value-date="2024-11-18">-50643.93</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cb62b393-0798-450c-bd0f-1b383798dc23">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-11-17" />
			<value currency="USD" value-date="2023-11-17">-113155.66</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f0ff0752-93c3-4bcf-801e-972229a9aa05">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-10-12" />
			<value currency="USD" value-date="2021-10-12">26687739.21</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="89ca9fac-6b80-41e9-a605-a7d9a06b6102">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-05-23" />
			<value currency="USD" value-date="2019-05-23">27906855.82</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="44830c2f-378b-4ca3-9c5a-8a53f62f4053">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-11-16" />
			<value currency="USD" value-date="2020-11-16">-10597943.65</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fe33a5db-6e47-47e7-868b-c01792e0fcac">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-11-16" />
			<value currency="USD" value-date="2020-11-16">23297816.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="43d00a4a-a377-4c9c-b687-d1807cafab6a">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-02-21" />
			<value currency="USD" value-date="2020-02-21">1349005.23</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="ef1f9e18-dc4c-491c-8d2a-d54e96bc6b2a">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-11-14" />
			<value currency="USD" value-date="2024-11-14">-50643.93</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="598cebff-2030-46cc-ae04-5052daca0689">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-05-24" />
			<value currency="USD" value-date="2019-05-24">3016642.85</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1a17cbdf-365e-4d69-973e-7cce468d12bb">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-11-09" />
			<value currency="USD" value-date="2023-11-09">-113155.66</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="59847404-16fa-4b1e-835a-d1a2439af7a0">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-01-13" />
			<value currency="USD" value-date="2022-01-13">5783776.83</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b070791b-4139-425f-8682-1af882e09f69">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-04-14" />
			<value currency="USD" value-date="2022-04-14">360203.91</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="aa2aa23c-4c10-4692-ba1f-a207644fdab9">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-09-12" />
			<value currency="USD" value-date="2019-09-12">4578932.12</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="7bb8abca-238a-43bb-8330-b9a464375e42">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-14" />
			<value currency="USD" value-date="2021-10-14">6154571.11</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d06e5400-0c14-4d1e-a43b-5bdd7515c05e">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-04-02" />
			<value currency="USD" value-date="2020-04-02">3680841.32</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e38b54fd-4608-4d12-b73a-cbeb850fb770">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-03-12" />
			<value currency="USD" value-date="2021-03-12">4779743.33</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="db9bc63d-8cac-4061-b488-6b9b2c46c0e1">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-10-14" />
			<value currency="USD" value-date="2021-10-14">2130467.39</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="59022b53-1148-4db2-a678-b4efbd28d2db">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-06-01" />
			<value currency="USD" value-date="2021-06-01">10131184.52</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c49703c7-c814-49d2-b183-df57f3c54978">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-07-29" />
			<value currency="USD" value-date="2020-07-29">4683490.65</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fb208783-d0e5-4bc7-bfb8-466a2718ed52">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-06-01" />
			<value currency="USD" value-date="2024-06-01">559952.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8c1b788d-20ed-48ba-8791-993a7a2d2945">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-04-14" />
			<value currency="USD" value-date="2022-04-14">2651001.69</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="350f9af0-2e35-412e-a2b4-b805a9a12c9b">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-05-05" />
			<value currency="USD" value-date="2022-05-05">4513083.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b552a3c2-dc02-4c40-ad48-cce6d0264896">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-11-19" />
			<value currency="USD" value-date="2020-11-19">6489478.34</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a2d67b18-6f18-4d81-92dc-ddf600065931">
			<transaction-type code="3" />
			<transaction-date iso-date="2024-06-01" />
			<value currency="USD" value-date="2024-06-01">1578015.74</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b6dc35b1-0f31-4158-a343-145061b989b9">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-01-13" />
			<value currency="USD" value-date="2022-01-13">2956667.54</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to ZAF-C-AFSAP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">AIDS Foundation South Africa (AFSA)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/ZAF-C-AFSA" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for ZAF-C-AFSAP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HR-Other 1: Percentage of police in Global Fund-supported districts reached by training in diversity, dignity and police program</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="500" />
					<actual value="593" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="500" />
					<actual value="0" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="1000" />
					<actual value="222" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="500" />
					<actual value="593" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adolescent girls and young women (AGYW) using PrEP</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="18.00" />
					<actual value="20.80" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="5.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-09-30" />
					<target value="6.00" />
					<actual value="8.00" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="12.00" />
					<actual value="9.50" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="18.00" />
					<actual value="20.80" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="15.00" />
					<actual value="7.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HIV-Other 2: Percentage of AGYW who receive economic strengthening based on an agreed package</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="16.88" />
					<actual value="6.60" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="42.20" />
					<actual value="6.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">CRS-Other 1: Percentage  of CSO with  capacity building plans implemented</narrative>
				</title>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of adolescent girls and young women (AGYW) who were tested for HIV and received their results during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="95527" />
					<actual value="103805" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="38211" />
					<actual value="51746" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="57316" />
					<actual value="52059" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="28093" />
					<actual value="3935" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-09-30" />
					<target value="31878" />
					<actual value="27831" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="31679" />
					<actual value="30784" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="34535" />
					<actual value="38685" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">CRS-Other 2: Percentage of MDIPs that include the needs and priorities of key and vulnerable populations (MSM, SW, AGYW and TG)</narrative>
				</title>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="100.00" />
					<actual value="92.90" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adolescent girls and young women (AGYW) reached with HIV prevention programs- defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="10.00" />
					<actual value="2.80" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-09-30" />
					<target value="20.00" />
					<actual value="14.20" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="53.53" />
					<actual value="38.40" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="53.53" />
					<actual value="48.50" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="15.00" />
					<actual value="15.70" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="30.00" />
					<actual value="24.30" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="53.50" />
					<actual value="48.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">YP-Other 1: Number of male partners of AGYW who were tested for HIV and received their results during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="28599" />
					<actual value="49206" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="44064" />
					<actual value="20928" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2021-09-30" />
					<target value="92656" />
					<actual value="76056" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="154427" />
					<actual value="159060" />
				</period>
				<period>
					<period-start iso-date="2020-04-01" />
					<period-end iso-date="2020-09-30" />
					<target value="42898" />
					<actual value="46980" />
				</period>
				<period>
					<period-start iso-date="2019-04-01" />
					<period-end iso-date="2019-09-30" />
					<target value="11016" />
					<actual value="1248" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="61771" />
					<actual value="83004" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">HR -Other 2: Number of analytical reports generated from a functional national HR reporting system on human rights violations based on inputs from local level users</narrative>
				</title>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="4" />
					<actual value="4" />
				</period>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="2" />
					<actual value="2" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="4" />
					<actual value="4" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of newly diagnosed people linked to HIV care (individual linkage)</narrative>
				</title>
				<period>
					<period-start iso-date="2020-10-01" />
					<period-end iso-date="2021-03-31" />
					<target value="90.00" />
					<actual value="34.90" />
				</period>
				<period>
					<period-start iso-date="2019-10-01" />
					<period-end iso-date="2020-03-31" />
					<target value="90.00" />
					<actual value="63.80" />
				</period>
				<period>
					<period-start iso-date="2021-04-01" />
					<period-end iso-date="2022-03-31" />
					<target value="90.00" />
					<actual value="59.10" />
				</period>
				<period>
					<period-start iso-date="2021-10-01" />
					<period-end iso-date="2022-03-31" />
					<target value="90.00" />
					<actual value="59.10" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>